Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer Schering Pharma announces soluble guanylyl cyclase activators

Feb. 25, 2016

F. Hoffmann-La Roche patents HBsAg inhibitors

Feb. 25, 2016

Neutrophil elastase inhibitors described in Boehringer Ingelhiem patents

Feb. 24, 2016

Pharmacyclics introduces BTK inhibitors

Feb. 24, 2016

Merck & Co. patents free fatty acid receptor 1 agonists

Feb. 24, 2016

Boehringer Ingelheim and Hydra Biosciences disclose TrpC5 inhibitors

Feb. 24, 2016

Janssen Pharmaceutica patents mGlu2 receptor negative allosteric modulators

Feb. 23, 2016

Nuevolution announces Brd4 inhibitors

Feb. 23, 2016

Boehringer Ingelheim Pharma discloses neutrophil elastase inhibitors

Feb. 23, 2016

University of Oklahoma introduces RPE65 proteins

Feb. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...